@AACR Top Trials from Day 4

AACR 2026 现场信号· @ · X·2026-04-22 03:27· 2026-04-22Score60

Body · original

Heat 2 · 1 like · 0 replies · 1 repost

Conference abstracts

CT028NCT06237881matched by NCT NCT06237881

Results of first-in-human, Phase 1 study of KSQ-001EX, an autologous tumor infiltrating lymphocyte therapy engineered to inactivate the SOCS1 gene, in patients with select advanced solid tumors

Rodabe N. Amaria, Hussein A. Tawbi, Alexandra Ikeguchi, Isabella C. Glitza-Oliva, Jennifer L. McQuade, Michael A. Davies, Youlia Petrova, Cara Haymaker, Chantale Bernatchez, Marie-Andree Forget, Karrie Wong, Erica R. Tobin, Micah J. Benson, Anna Truppel-Hartmann, Patricia M. Harris

Read the abstract →

3721NCT06237881matched by NCT NCT06237881

Anti-tumor function and long-term persistence of KSQ-001EX, a SOCS1-edited eTIL® therapy, independent of IL-2 co-administration

Dipen Sangurdekar, Erica Tobin, Karrie Wong, Ashish Yeri, Alex Smashnov, Kelly Bowen, Giorgio Sarkis, Violetta Medik, Hsinyi Lu, Sevinj Isgandarova, Michelle Carrasco, Patricia Harris, Cara L. Haymaker, Micah Benson, Anna Truppel-Hartmann, Rodabe N. Amaria

Read the abstract →

Source: AACR 2026 现场信号 · x.com